cv 3988 has been researched along with malondialdehyde in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeuchi, H; Mason, AD; Pruitt, BA; Sakano, T; Sanchez, J | 1 |
1 other study(ies) available for cv 3988 and malondialdehyde
| Article | Year |
|---|---|
The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model.
Topics: Animals; Dinoprostone; Lipid Peroxidation; Male; Malondialdehyde; Phospholipid Ethers; Platelet Activating Factor; Platelet Count; Sheep; Smoke Inhalation Injury; Thromboxane B2; Time Factors | 1992 |